The structural and organizational aspects of human papillomavirus vaccine affecting immunization coverage in Europe: a systematic review
File(s)
Published version
Author(s)
Valdecantos, Ronan Lemwel
Sorrentino, Michele
Mercogliano, Michelangelo
Giordano, Vincenzo
Trama, Ugo
Type
Journal Article
Abstract
The introduction of HPV vaccinations, that can prevent most prevalent HPV-related cancers of various body districts, is a public health milestone. Despite broad immunization programs, European Health Systems face structural and organizational difficulties that hinder care. This study examined structural and organizational elements that may affect HPV vaccine coverage. We searched numerous databases from January 1, 1995 to May 15, 2023, for literature on HPV immunization research methodologies. Structural and Organizational aspects that cause HPV vaccine concerns in women and men were examined in the outcome evaluations and the research examined vaccination willingness factors. Ottawa, JBI's critical appraisal tool, and Amstar quality assessment assessed bias. A total of 10 articles from 312 studies met the inclusion criteria. Studies were undertaken in Italy, Belgium, England, Switzerland, France, the UK, and Spain. There were also combined-diverse studies in 15 and 27 European countries. Several primary healthcare strategies have increased HPV vaccination rates. These include vaccine procurement and cost-effectiveness, school-based immunization programs, electronic health databases, health professional training, health education and communication, and monitoring and surveillance.
Date Issued
2025-04-03
Date Acceptance
2025-03-17
Citation
BMC Public Health, 2025, 25
ISSN
1471-2458
Publisher
BMC
Journal / Book Title
BMC Public Health
Volume
25
Copyright Statement
© The Author(s) 2025.. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
License URL
Identifier
10.1186/s12889-025-22343-w
Subjects
Human papillomavirus
Cancer
Vaccine
Vaccination programs
Sexually transmitted infection
Europe
Publication Status
Published
Article Number
1254
Date Publish Online
2025-04-03